Chapter 6

The Terms

JULIANNA

My wrists ache where the plastic was. The bruises from Thorne's grip have added a new layer over Phoenix's marks, compound bruising the color of a storm coming in. I rub my thumb across my inner wrist, where the worst of it lives, and let the pain live within me.

I don't know what happens next.

This is the thing about captivity. Even voluntary captivity, even captivity I've determined is the correct punishment for what I've done.

The uncertainty of what comes next is its own kind of pressure, separate from guilt and fear. I don't know when I'll be brought out. I don't know who will bring me. I don't know whether the next few hours will require me to function or whether I'll simply wait here until someone decides I'm needed.

I stand in the center of the room, eight feet by ten, and I let the facts arrange themselves into their correct columns. The most important fact, the one that sits at the top of every column, the one the rest of the accounting organizes itself around, is Lily.

Lily carries ML-273 in her blood. I built the mechanism that put it there, and she waved at me because she is six years old. That's what a kid does when they see a new person.

My hand came up because some part of me has not settled my debt.

Her father is going to use that against me if I give him reason to.

I won't give him a reason.

Not because I doubt he would follow through on the threat. That part is obvious. Thorne doesn't posture. He doesn't bluff. When he states a boundary, he states it like a structural load: something real that will collapse if I push it far enough.

I'm not going to push.

What stops me has nothing to do with my own survival. It's the other possibility. The one he implied without saying it out loud. If I cross that line, if I step into Lily's world, even by accident, he will not remove me from proximity to her.

He will remove me entirely.

Not quickly.

Not cleanly.

The disturbing part is not the violence itself. It's the certainty that he will do it slowly. Methodically. With the same controlled focus he brings to everything else. Not out of rage.

Out of fatherly protection.

My mind understands that dynamic perfectly. I designed systems that behave the same way. When a threat to the core system is identified, you isolate it. Contain it. Eliminate it if necessary.

From Thorne's perspective, I'm not a person. I'm the villain who harmed his child.

The fear that tightens in my chest isn't about what he might do to me. It's about what will happen to him if I force him to do it. Because the moment he stops being Lily's father and becomes the man who destroys the person responsible for hurting her, something in him will break.

Something permanent.

I've already taken enough from that child. I'm not going to take her father from her too.

I'll keep to myself, and I'll keep my distance. Which is easy right now, considering I'm alone and locked in what basically amounts to a cell.

The silence here is absolute. I walk to the mattress and sit on the edge. At least it's clean. It doesn't smell like fear and old sweat the way the Ghostwater holding cell did.

The LED panel in the ceiling throws sterile white light across the concrete walls.

You're going to save her. Thorne's voice in the control room runs on a loop in my head.

The moment he aimed his weapon, I'd already done the accounting. My life is valued at zero. A highly reasonable, mathematically sound exchange for the safety of the patients in Meridian's ML-273 trial. I was prepared for the bullet. It was the only clean payout left.

But he didn't pull the trigger.

A man who shatters into a thousand pieces on a gravel driveway for a child is not a blunt-force weapon.

He is capable of staggering, life-altering devastation.

And a man who looked at me the way he did after letting Lily go, with a hatred so pure it has physical mass, is not someone who will ever see me as a human being.

He will only ever see me as the architect of his daughter's suffering.

Cinder blocks and mortar. I trace the mortar line closest to the mattress with my right index finger. Four-to-one ratio. Sand and cement. Even in a room designed to contain me, the construction is honest about what it is.

I respect that.

I drop my head into my hands, and the weight of the silence presses in.

Then I let the numbers do what they always do.

Not counting. Never counting.

The rules begin moving through my head in the quiet, mechanical sequence I learned as a child, nearly the same age Lily is now: double the digit, add the neighbor, subtract from nine, carry the remainder forward.

Each step triggers the next before the previous one has fully settled, the structure assembling itself in layers behind my eyes.

The Trachtenberg patterns don't hesitate. They don't reconsider. Once the sequence starts, it runs to completion exactly as designed.

Clean.

Predictable.

Unaffected by anything happening in the room.

My lips move as the operations stack in my head, the words barely audible.

Double … Neighbor … Subtract …

The rhythm steadies my breathing. Each rule locks into the next like gears engaging, the calculation unfolding with the quiet certainty of a system that has never once cared about fear, or anger, or the weight of a child waving from across a yard.

Numbers are honest. They do exactly what they're told. They stay where I put them.

And then, because my mind does what it does when given enough quiet, the comfort of math tips over into the actual problem.

They need the patient distribution manifests for the ML-273 trial. Every adult and child who received the compound. Here's what they don't understand yet, because I haven't told them, and they haven't asked the right question: there is no list to retrieve.

Phoenix designed the distribution architecture with one absolute security constraint.

The master patient directory was never committed to any system it didn't control.

No external backup. No accessible archive.

The distribution data lives inside Phoenix's encrypted network and inside one other location.

My head.

Not the names. Phoenix kept the names. The specific coordinators, the specific clinics, the specific children. Phoenix was careful about that. A human architect who holds the full directory can defect with it.

I created the design, but the directory was always Phoenix's.

What I hold is something more foundational and, for their purposes, more immediately useful than a list of names I don't have access to.

I built the model that determined what a qualifying regional coordinator required. The precise institutional fingerprint each distribution hub had to match.

Geographic coverage radius.

Patient volume.

Post-remission trial enrollment capacity. The financial intake structure required to absorb Meridian's funding without triggering reporting thresholds.

I built those parameters with the same meticulous detail I bring to every financial architecture, because Phoenix demanded precision, and because I'm exceptional at my job. Because I told myself for a long time that being good at the work meant the work was good.

I was wrong about the last part.

But the parameters are intact. Every one of them.

The team already has one confirmed institution.

I gathered that from the briefing before they locked the door.

A Northeast anchor. A children's hospital.

CHOP meets the requirements of the Northeast tier.

That match is not a coincidence. It's my model functioning as designed.

One confirmed institution means the profile holds.

It means I can describe the remaining sites with sufficient precision for them to be found.

I begin the only way I know how: from the structure outward.

Geographic dispersal engineered to prevent clustering that would trigger CDC epidemiological flags. The Northeast anchor carries the highest volume: a major research hospital with a dedicated immune-recovery ward and a post-remission cohort capacity of at least fifty patients.

The Southeast anchor requires proximity to high-density transit hubs, utilizing a decentralized financial intake structure to absorb Meridian's funding without tripping IRS reporting thresholds.

The Midwest tier needs a specific ratio of rural-to-urban trial access to mask the compound's true distribution curve …

A child's laughter seeps into the room.

It arrives without warning. Bright, completely unguarded. The specific four-second laughter of someone who has just discovered something delightful and cannot contain it.

There's no performance in it. No awareness of anyone listening. The laughter of a child who doesn't know she is being listened to, because she has not yet been given a reason to guard herself.

Lily.

The distribution model stops.

The entire architecture I was walking back into goes quiet, every load-bearing piece of it, and I sit in a concrete room and imagine the sound of the child I poisoned laughing because she doesn't know yet that there is anything else to do.

Four seconds.

I count them without meaning to.

The laughter fades. The hallway goes back to its ordinary sounds. The low ventilation hum, a distant keyboard, the muffled movement of men who have organized their lives around a six-year-old girl who laughs through walls.

The deficit in my chest doesn't have a column that accepts it. There's no line item for this. No accounting structure I've ever designed has a place for the sound of Lily's laughter arriving through concrete, and what it costs me, and the fact that I will pay it every time and keep going.

That's what compound interest means when the debt carries this kind of weight.

I press my palm flat against the wall.

Then I go back to the architecture.

Northeast anchor. Major pediatric research institution. Post-remission cohort. Volume capacity in the highest distribution tier. CHOP fits. Begin with the Southeast ...

The numbers are still there.

They stay where I put them. Every time.

That's accounting.

That's all there is.

If ads affect your reading experience, click here to remove ads on this page.